You can watch IMTXW and buy or sell other stocks, options, and ETFs commission-free!
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. The firm's clinical pipelines include adoptive cell therapy (ACT) and TCR biscpecifics (TCER™).
Harpreet Singh-Jasuja, PhD
Tuebingen, Baden Wuerttemberg
52 Week High
52 Week Low